Cognitive enhancement and neuroprotective effects of OABL, a sesquiterpene lactone in 5xFAD Alzheimer's disease mice model

• Published in: Redox biology 2022-04, Vol.50, p.102229-102229, Article 102229
• Main Authors: Tang, Jiang-Jiang, Huang, Lan-Fang, Deng, Jia-Le, Wang, Yi-Meng, Guo, Cong, Peng, Xiao-Na, Liu, Zhigang, Gao, Jin-Ming
• Format: Article
• Language: English
• Subjects: 1,6-O,O-Diacetylbritannilactone (OABL); 5xFAD mice; Alzheimer Disease - metabolism; Alzheimer's disease; Amyloid beta-Peptides - metabolism; Amyloid Precursor Protein Secretases; Animals; Aspartic Acid Endopeptidases; Cognition; Disease Models, Animal; Lactones - pharmacology; Lactones - therapeutic use; Mice; Mice, Transgenic; Microglia; Neurodegenerative Diseases; Neuroinflammation; Neuroprotection; Neuroprotective Agents - pharmacology; Neuroprotective Agents - therapeutic use; Rats; Research Paper; Sesquiterpenes - pharmacology
• ISSN: 2213-2317; 2213-2317
• DOI: 10.1016/j.redox.2022.102229

Alzheimer's disease (AD) is a neurodegenerative disease in which oxidative stress and neuroinflammation were demonstrated to be associated with neuronal loss and cognitive deficits. However, there are still no specific treatments that can prevent the progression of AD. In this study, a screening of anti-inflammatory hits from 4207 natural compounds of two different molecular libraries indicated 1,6-O,O-diacetylbritannilactone (OABL), a 1,10-seco-eudesmane sesquiterpene lactone isolated from the herb Inula britannica L., exhibited strong anti-inflammatory activity in vitro as well as favorable BBB penetration property. OABL reduced LPS-induced neuroinflammation in BV-2 microglial cells as assessed by effects on the levels of inflammatory mediators including NO, PGE2, TNF-α, iNOS, and COX-2, as well as the translocation of NF-κB. Besides, OABL also exhibited pronounced neuroprotective effects against oxytosis and ferroptosis in the rat pheochromocytoma PC12 cell line. For in vivo research, OABL (20 mg/kg B.W., i.p.) for 21 d attenuated the impairments in cognitive function observed in 6-month-old 5xFAD mice, as assessed with the Morris water maze test. OABL restored neuronal damage and postsynaptic density protein 95 (PSD95) expression in the hippocampus. OABL also significantly reduced the accumulation of amyloid plaques, the Aβ expression, the phosphorylation of Tau protein, and the expression of BACE1 in AD mice brain. In addition, OABL attenuated the overactivation of microglia and astrocytes by suppressing the expressions of inflammatory cytokines, and increased glutathione (GSH) and reduced malondialdehyde (MDA) and super oxide dismutase (SOD) levels in the 5xFAD mice brain. In conclusion, these results highlight the beneficial effects of the natural product OABL as a novel treatment with potential application for drug discovery in AD due to its pharmacological profile. •OABL exhibits pronounced anti-neuroinflammatory and neuroprotective effects.•OABL alleviates the cognitive deficits in 5xFAD mice.•OABL reduces Aβ accumulation and p-Tau level in the CNS of 5xFAD mice.•OABL attenuates the overactivation of microglia and astrocytes in 5xFAD mice.•OABL balances the GSH, SOD and MDA levels in the cortex of 5xFAD mice.